Goldman Sachs Starts TherapeuticsMD (TXMD) at Buy

April 4, 2016 6:35 AM EDT
Get Alerts TXMD Hot Sheet
Price: $1.05 --0%

Rating Summary:
    12 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 11 | New: 17
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Goldman Sachs initiated coverage on TherapeuticsMD (NYSE: TXMD) with a Buy rating and a price target of $10.00.

For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.

Shares of TherapeuticsMD closed at $6.62 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage

Related Entities

Goldman Sachs